Contribution of factor analysis of dynamic studies to somatostatin receptor imaging in the diagnosis of medullary thyroid carcinoma;Apport de l'analyse factorielle des structures dynamiques a l'imagerie des recepteurs de la somatostatine dans le diagnostic des cancers medullaires de la thyroide

Medecine Nucleaire

Volumn 21, Issue 4, 1997, Pages 219-225

  Kolesnikov Gauthier, H ^a   Huglo, D ^a   Nocaudie, M ^a   Marchandise, X ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

111In pentetreotide; Factor analysis; Medullary thyroid carcinoma; Somatostatin receptor imaging

Indexed keywords

PENTETREOTIDE IN 111; SOMATOSTATIN RECEPTOR;

ARTICLE; CLINICAL ARTICLE; HUMAN; KINETICS; PARAGANGLIOMA; PATHOPHYSIOLOGY; THYROID MEDULLARY CARCINOMA; THYROID SCINTISCANNING;

EID: 0030832232     PISSN: 09281258     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Delisle MJ Le cancer médullaire de la thyroide et les syndromes de néoplasie endocrinienne multiple Rev Prat 1992 ; 42 : 845-50
2. Kwekkeboom DJ, Reubi JC, Lamberts SWJ In vivo somatostatin receptor imaging in medullary thyroid carcinoma. J Clin Endocrinol Metab 1993 , 76 : 1413-17
3. Proye C, Marmousez T, l'Association française de chirurgie endocrinienne et le Groupe français d'étude des tumeurs à calcitonine. Cancer médullaire de la thyroide . moyens thérapeutiques, chirurgie de première intention In : Calmettes C, Guliana JM, eds. Medullary thyroid carcinoma. Colloque Inserm Paris : Éditions Inserm, 1991 : 199-205
4. Guilloteau D, Bellet D Calcitonine et ACE pour le dépistage et le suivi des CMT. In Calmettes C, Guliana JM, eds Medullary thyroid carcinoma. Colloque Inserm Paris Éditions Inserm, 1991 : 73-81
5. 10, 10 p
6. Schlumberger M, Gardet P, de Vathaire F External radiotherapy and chemotherapy in medullary thyroid carcinoma patients. In: Calmettes C, Guliana JM, eds. Medullary thyroid carcinoma Colloque Inserm. Paris . Éditions Inserm, 1991 211-3
7. Reubi JC, Krenning E, Lamberts SWJ. Somatostatin receptors in human cancer . incidence, characteristics, tunctionnal correlates and clinical implications. J Steroid Biochem Molec Biol 1992 ; 43 : 27-32
8. Reubi JC, Chayvialle JA, Franck B Somatostatin receptors and somatostatin content in medullary thyroid carcinomas. Lab Invest 1991 ; 64 : 567-73
9. Lamberts SWJ, Krenning EP, Reubi JC.The role of somatostatin and its analogs in the diagnosis and treatment of tumors. Endocr Rev 1991 ;12 : 450-82
10. 123I-Tyr-3)-octreotide : the Rotterdam experience with more than 1000 patients. Eur J Nucl Med 1993; 20 : 716-31
11. Schwartz C, Deliste MJ, Maes B. Is somatostatin receptor scintigraphy useful to localize metastases or reccurence of medullary thyroid carcinoma ? Eur J Nur J Med 1995 ; 22 : 910 [abstract 741]
12. Krausz Y, de Jong RBJ, Glaser G. Somatostatin receptor scintigraphy of endocrine tumors. J Nucl Med 1993 ; 34 164 [abstract 799]
13. Ozturk E, Gunalp B, Ozguven M.The visualization of granulomatous disease with somatostatin receptor scintigraphy. Clin Nucl Med 1994 ; 19 : 129-32
14. Lamberts SWJ, Reubi JC, Krenning EP. Validation of somatostatin receptor scintigraphy in the localization of neuroendocrine tumors Acta Oncol 1993 , 32 . 167-70
15. Lumbroso J, Baudin E, Giammarile F. Indium-111-DTPA-octreotide scintigraphy for detecting medullary thyroid carcinoma. J Nucl Med 1995 ; 36 : 203 [abstract 915]
16. 99mTc(V)-dimercaptosuccinic acid studies in the imaging of recurrent medullary thyroid carcinoma. J Endocrinol 1995 ; 144 . 339-45
17. Dorr U, Sautter-Bihl ML, Bihl H The contribution of somatostatin receptor scintigraphy to the diagnosis of recurrent medullary carcinoma of the thyroid. Semin Oncol 1994 , 21 (suppl 13) : 42-5
18. Dorr U, Franck-Raue K, Raue F. The potential value of somatostatin receptor scintigraphy in medullary thyroid carcinoma. Nucl Med Commun 1993 , 14 : 439-45
19. Houston AS, Macleod MA, Sampson FD Principal components analysis as an aid to classification of renal dynamic studies. Eur J Nucl Med 1979 ; 4 : 295-9
20. Samal M, Surova H, Karny M. Enhancement of physiological factors in factor analysis of dynamic studies. Eur J Nucl Med 1986 ; 12 . 280-3
21. Petras S, Aurengo A, Le D. Factor analysis in successive hepatobiliary imaging of native and transplant livers. J Nucl Med 1996 , 37 : 847-51
22. Cavailloles F, Bazin JP, Di Paola R. Factor analysis in gated cardiac studies. J Nucl Med 1984 , 25 . 1067-79
23. Frouin F, Bazin JP, Di Paola R. Famis : a software package for functional feature extraction from biomedical multidimensional images. Comput Med Im Graph 1992 , 16 : 81-9
24. Hannequin P, Liehn JC, Valeyre J L'analyse des séquences d'images en médecine nucléaire . 2. Application des méthodes dites d'analyse factonelle. J Mád Nucl Biophys 1989 , 13 : 125-37
25. Barber DC. The use of principal components in the quantitative analysis of gamma camera dynamic studies. Phys Med Biol 1980 ; 25 : 283-92
26. 10
27. 111In-DTPA-D-Phe-1-octreotide in man : metabolism, dosimetry and comparaison with iodine 123-Tyr-3-octreotide J Nucl Med 1992 ; 33 : 652-8
28. Reichlin S. Medical progress . somatostatin (first of two parts). N Engl J Med 1983 ; 309 . 1495-9
29. Bong SB, Vanderlaan JG, Louwes H, Schuurman JJ. Clinical experience with somatostatin receptor imaging in lymphoma Sem Oncol 1994 ; 21 (suppl 13) : 46-50